Related Experiment Video
Updated: Mar 3, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders
1Cardiologicum Hamburg, Hamburg, Germany.
Insights
Non-vitamin K antagonist oral anticoagulants (NOACs) are standard for atrial fibrillation stroke prevention. For patients with bleeding risks, Left Atrial Appendage (LAA) occlusion using devices like WATCHMAN offers a safe and effective alternative.
Area of Science:
- Cardiology
- Medical Devices
- Stroke Prevention
Background:
- Non-vitamin K antagonist oral anticoagulants (NOACs) are the current standard for stroke prevention in patients with atrial fibrillation.
- Some patients experience extracranial bleeding or have contraindications for pharmacologic anticoagulation.
Purpose of the Study:
- To evaluate the safety and efficacy of Left Atrial Appendage (LAA) occlusion as a non-pharmacologic stroke protection strategy.
- To highlight the role of devices like WATCHMAN in managing stroke risk in specific patient populations.
Main Methods:
- Review of clinical data and guidelines pertaining to LAA occlusion devices.
- Assessment of the safety and efficacy profile of the WATCHMAN device for stroke prevention.
Main Results:
- Left Atrial Appendage (LAA) occlusion with the WATCHMAN device is proven safe and effective.
- This therapy is now recommended in current guidelines for patients with atrial fibrillation who require non-pharmacologic stroke protection.
Conclusions:
- LAA occlusion represents a vital alternative for stroke prevention in atrial fibrillation patients unsuitable for NOAC therapy.
- The WATCHMAN device is a key option, with other devices also emerging for this indication.
Abstract:
NOAC therapy has become the standard for stroke prevention in patients with atrial fibrillation. Yet some patients suffer extracranial bleeding events or have other reasons to seek non-pharmacologic stroke protection. LAA occlusion with the WATCHMAN device has been proven safe and effective for such patients and is now recommended in current guidelines for this patient group; other devices also seek approval.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Aneurysm III: Interprofessional Care
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management

